Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer

CONCLUSION: GS chemotherapy after curative surgery was well tolerated, showed better clinical benefit in the adjuvant setting, and can effectively reduce BTC recurrence.PMID:34515195 | DOI:10.1159/000518094

Source: Oncology - September 13, 2021 Category: Cancer & Oncology Authors: Kiyotaka Hosoda Kentaro Fukushima Akira Shimizu Hiroaki Motoyama Koji Kubota Tsuyoshi Notake Shinsuke Sugenoya Hikaru Hayashi Koya Yasukawa Ryoichiro Kobayashi Yuji Soejima Source Type: research